Ogo Egbuna

1.8k total citations · 1 hit paper
37 papers, 1.3k citations indexed

About

Ogo Egbuna is a scholar working on Nephrology, Oncology and Surgery. According to data from OpenAlex, Ogo Egbuna has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in Ogo Egbuna's work include Bone health and treatments (8 papers), Parathyroid Disorders and Treatments (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Ogo Egbuna is often cited by papers focused on Bone health and treatments (8 papers), Parathyroid Disorders and Treatments (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Ogo Egbuna collaborates with scholars based in United States, Canada and United Kingdom. Ogo Egbuna's co-authors include Edward M. Brown, Martha Pavlakis, Martin S. Zand, Paul D. Miller, Didier A. Mandelbrot, James R. Rodrigue, Amy D. Waterman, Matthew Paek, Martin R. Pollak and Edward Franek and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ogo Egbuna

34 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations Ogo Egbuna, George Manos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ogo Egbuna United States	18	553	371	322	291	230	37	1.3k
Henry Fehrenbach Germany	16	229 0.4×	156 0.4×	73 0.2×	315 1.1×	101 0.4×	21	1.1k
Biruh Workeneh United States	15	381 0.7×	225 0.6×	14 0.0×	354 1.2×	148 0.6×	55	1.2k
Richard Brasington United States	22	138 0.2×	146 0.4×	100 0.3×	158 0.5×	191 0.8×	41	1.7k
Monica Cortinovis Italy	17	312 0.6×	91 0.2×	14 0.0×	253 0.9×	438 1.9×	36	1.3k
Marina Charbit France	22	571 1.0×	70 0.2×	8 0.0×	405 1.4×	173 0.8×	62	1.6k
Joseph Shaker United States	19	380 0.7×	260 0.7×	206 0.6×	173 0.6×	419 1.8×	48	1.4k
Mysore K. Phanish United Kingdom	16	293 0.5×	128 0.3×	11 0.0×	369 1.3×	161 0.7×	28	1000
Peter E. Gower United Kingdom	16	204 0.4×	53 0.1×	60 0.2×	260 0.9×	119 0.5×	25	652
Luca Dello Strologo Italy	20	274 0.5×	81 0.2×	8 0.0×	200 0.7×	175 0.8×	72	1.3k
Alan G. Birtch United States	14	109 0.2×	139 0.4×	28 0.1×	90 0.3×	267 1.2×	26	985

Countries citing papers authored by Ogo Egbuna

Since Specialization

Citations

This map shows the geographic impact of Ogo Egbuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ogo Egbuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ogo Egbuna more than expected).

Fields of papers citing papers by Ogo Egbuna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ogo Egbuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ogo Egbuna. The network helps show where Ogo Egbuna may publish in the future.

Co-authorship network of co-authors of Ogo Egbuna

This figure shows the co-authorship network connecting the top 25 collaborators of Ogo Egbuna. A scholar is included among the top collaborators of Ogo Egbuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ogo Egbuna. Ogo Egbuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yalavarthy, Rajesh, Ju-Young Moon, Inwhee Park, et al.. (2025). Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. Kidney International Reports. 11(1). 106–116.

Egbuna, Ogo, et al.. (2024). Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, Following Single- and Multiple-ascending Doses in Healthy Adults. SHILAP Revista de lepidopterología. 4(1). 64–73. 3 indexed citations

Knebelmann, Bertrand, Kate Bramham, Kieran McCafferty, et al.. (2023). #2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE. Nephrology Dialysis Transplantation. 38(Supplement_1).

Falk, Ronald J., Laura Barisoni, David J. Friedman, et al.. (2022). Design of a Phase 2/3 Adaptive Trial Evaluating Inaxaplin in APOL1-Mediated Kidney Disease. Journal of the American Society of Nephrology. 33(11S). 181–182. 1 indexed citations

Schemitsch, Emil H., Theodore Miclau, Theofilos Karachalios, et al.. (2020). A Randomized, Placebo-Controlled Study of Romosozumab for the Treatment of Hip Fractures. Journal of Bone and Joint Surgery. 102(8). 693–702. 60 indexed citations

Lü, Hong, Wei‐Li Chen, Hongrong Xu, et al.. (2019). <p>A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects</p>. Clinical Pharmacology Advances and Applications. Volume 11. 145–153. 2 indexed citations

Subramanian, Raju, Xiaochun Zhu, M. Benjamin Hock, et al.. (2016). Pharmacokinetics, Biotransformation, and Excretion of [14C]Etelcalcetide (AMG 416) Following a Single Microtracer Intravenous Dose in Patients with Chronic Kidney Disease on Hemodialysis. Clinical Pharmacokinetics. 56(2). 179–192. 21 indexed citations

LeBlanc, Erin S., A. Gabriela Rosales, Akhila Balasubramanian, et al.. (2014). Risk factors for fracture among current, persistent users of bisphosphonates. Osteoporosis International. 26(2). 713–725. 6 indexed citations

Block, Geoffrey A., Ogo Egbuna, Steven Zeig, et al.. (2014). The evaluation of denosumab safety in patients with chronic kidney disease: An open-label study.. Journal of Clinical Oncology. 32(15_suppl). e20649–e20649. 5 indexed citations

10.

Rodrigue, James R., Matthew Paek, Ogo Egbuna, et al.. (2013). Willingness to Pursue Live-Donor Kidney Transplantation Among Waitlisted Patients Infected With Human Immunodeficiency Virus (HIV). Transplantation. 95(6). 787–790. 6 indexed citations

11.

Samelson, Elizabeth J., Paul D. Miller, Claus Christiansen, et al.. (2013). RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk. Journal of Bone and Mineral Research. 29(2). 450–457. 92 indexed citations

12.

Quinn, Stephen, A. Thomsen, Ogo Egbuna, et al.. (2013). CaSR-mediated interactions between calcium and magnesium homeostasis in mice. American Journal of Physiology-Endocrinology and Metabolism. 304(7). E724–E733. 24 indexed citations

13.

Rodrigue, James R., Martha Pavlakis, Ogo Egbuna, et al.. (2012). The “House Calls” Trial: A Randomized Controlled Trial to Reduce Racial Disparities in Live Donor Kidney Transplantation: Rationale and Design. Contemporary Clinical Trials. 33(4). 811–818. 44 indexed citations

14.

Egbuna, Ogo, Roger B. Davis, Martha Pavlakis, et al.. (2009). Outcomes With Conversion From Calcineurin Inhibitors to Sirolimus After Renal Transplantation in the Context of Steroid Withdrawal or Steroid Continuation. Transplantation. 88(5). 684–692. 7 indexed citations

15.

Egbuna, Ogo, Steven Quinn, Lakshmi Kantham, et al.. (2009). The full-length calcium-sensing receptor dampens the calcemic response to 1α,25(OH)₂ vitamin D₃ in vivo independently of parathyroid hormone. American Journal of Physiology-Renal Physiology. 297(3). F720–F728. 27 indexed citations

16.

Egbuna, Ogo & Edward M. Brown. (2008). Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Practice & Research Clinical Rheumatology. 22(1). 129–148. 123 indexed citations

17.

Egbuna, Ogo, Scott R. Johnson, & Martha Pavlakis. (2007). Rupture of an Infected Liver Cyst Into the Pericardium in a Kidney Transplant Recipient With Polycystic Kidney Disease. American Journal of Kidney Diseases. 49(6). 851–853. 10 indexed citations

18.

Egbuna, Ogo, Jeremy G. Taylor, David A. Bushinsky, & Martin S. Zand. (2007). Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clinical Transplantation. 21(4). 558–566. 72 indexed citations

19.

Egbuna, Ogo, Martha Pavlakis, & Isaac E. Stillman. (2007). Acute Crescentic Glomerulonephritis in a Renal Allograft: An Unusual Complication of Fungal Infection. American Journal of Kidney Diseases. 50(3). 468–470. 3 indexed citations

20.

Egbuna, Ogo, Martin S. Zand, Arnaldo Arbini, Marilyn A. Menegus, & J. Taylor. (2005). A Cluster of Parvovirus B19 Infections in Renal Transplant Recipients: A Prospective Case Series and Review of the Literature. American Journal of Transplantation. 6(1). 225–231. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact